Document Detail

Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
MedLine Citation:
PMID:  15319174     Owner:  NLM     Status:  MEDLINE    
No in vivo data exist about the relationship of circulating granulocyte-macrophage colony stimulating factor (GM-CSF) and soluble adhesion molecules ICAM-1 and VCAM-1 (sICAM-1 and sVCAM-1) to the severity of acute myocardial infarction (AMI) and the pathophysiological events of post-infarction left ventricular dysfunction. We investigated the kinetics of these inflammatory mediators in the plasma of patients with AMI, and correlated the findings with the clinical severity of the disease during the first week of hospitalization as well as the degree of left ventricular dysfunction one month after the AMI. Plasma levels of inflammatory markers were determined in 41 AMI patients (all received thrombolytic treatment) by ELISA assays, serially during the first week of hospitalization and one month after hospital admission. Patients (n = 20) with uncomplicated AMI (Killip class I) were classified as group A, patients (n = 21) with AMI complicated by heart failure manifestations (Killip classes II and III) were classified as group B, while 20 age- and sex-matched volunteers were used as healthy controls. A sustained increase in GM-CSF, sICAM-1 and sVCAM-1 plasma concentrations was observed only in group B during the first week of the study. Patients from group B exhibited significantly higher levels of GM-CSF (P < 0.01), sICAM-1 (P < 0.05) and sVCAM-1 (P < 0.01) than patients from group A and the healthy controls (P < 0.001). In group B patients, significant correlations were observed between the peak of GM-CSF levels and the peak of serum creatine kinase-MB (r = 0.42; P < 0.05), white blood cell counts (r = 0.67; P < 0.001) and LVEF (r =- 0.51; P < 0.01). At one month follow-up, patients (n = 17) with severe post-infarction left ventricular dysfunction (LVEF <or=35%) exhibited significantly higher levels of GM-CSF (21.8 +/- 1.5 versus 11.7 +/- 0.9 pg/mL, P < 0.001), sICAM-1 (331.4 +/- 18.4 versus 201.3 +/- 12.1 ng/mL, P < 0.001) and sVCAM-1 (748.4 +/- 34.7 versus 512.9 +/- 18.8 ng/mL, P < 0.001) than did the other patients (n = 24) without this condition (LVEF > 35%). Significant correlations were observed between GM-CSF levels and left ventricular end-diastolic volume index (r = 0.55; P < 0.001) or left ventricular end-systolic volume index (r = 0.49; P = 0.001). We have found a significant elevation of plasma GM-CSF and soluble adhesion molecules during the course of AMI, with the highest values in patients with AMI complicated by heart failure manifestations and severe left ventricular dysfunction. These monocyte-related inflammatory mediators may actively contribute to the pathophysiology of the disease and post-infarction cardiac dysfunction.
John T Parissis; Stamatis Adamopoulos; Koula Venetsanou; George Kostakis; Antonios Rigas; Spilios M Karas; Dimitrios Kremastinos
Related Documents :
15276104 - Assessment of biventricular remodeling by magnetic resonance imaging after successful p...
18268424 - Predictors of impaired heart rate variability and clinical outcome in patients with acu...
8644654 - Heart rate variability in the early hours of an acute myocardial infarction.
16464904 - Is technological change in medicine always worth it? the case of acute myocardial infar...
15642564 - Characteristics and outcomes of patients with acute myocardial infarction and angiograp...
14575384 - Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European cytokine network     Volume:  15     ISSN:  1148-5493     ISO Abbreviation:  Eur. Cytokine Netw.     Publication Date:    2004 Apr-Jun
Date Detail:
Created Date:  2004-08-20     Completed Date:  2005-02-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100879     Medline TA:  Eur Cytokine Netw     Country:  France    
Other Details:
Languages:  eng     Pagination:  139-44     Citation Subset:  IM    
First Department of Cardiology, Amalia Fleming Hospital, Athens Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Granulocyte-Macrophage Colony-Stimulating Factor / blood*
Intercellular Adhesion Molecule-1 / blood*
Middle Aged
Monokines / biosynthesis
Myocardial Infarction / blood*,  complications,  pathology
Predictive Value of Tests
Severity of Illness Index
Vascular Cell Adhesion Molecule-1 / blood*
Ventricular Dysfunction, Left / blood*,  etiology,  pathology
Reg. No./Substance:
0/Biological Markers; 0/Monokines; 0/Vascular Cell Adhesion Molecule-1; 126547-89-5/Intercellular Adhesion Molecule-1; 83869-56-1/Granulocyte-Macrophage Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High cytokine levels at admission are associated with fatal outcome in patients with necrotizing fas...
Next Document:  Limited effect of selected organic pollutants on cytokine production by peripheral blood leukocytes.